EquityBee Review 2026: Should You Fund Someone Else's Stock Options?

EquityBee has built its entire business on a problem most startup employees discover too late, according to the company's own platform: you can't afford to exercise your options after you leave.

Here's the version nobody puts in the recruiting deck. A startup employee gets a stock option grant: the right to buy company shares at a fixed price, called the strike price or exercise price, set by an independent appraisal known as a 409A valuation. The grant vests quietly for years while the employee builds features, closes deals, or answers pager duty at 2 a.m., and the basic mechanics of how that grant works are laid out in plain terms by the SEC's own investor education glossary. Then the employee quits, gets recruited away, or gets laid off, and discovers a clock has started. Under a standard plan, they have roughly 90 days to write a check for the exercise cost, plus cover the tax bill on the paper gain, or the options disappear back into the company's pool forever. Multiply a five- or six-figure strike price by tens of thousands of vested shares, add a tax hit that can run into six figures on top, and you understand why a large share of vested startup options simply go unexercised.

EquityBee exists to solve that cash problem, and in doing so it created something else: a way for accredited investors to buy exposure to late-stage, venture-backed startups they'd otherwise never get near. I want to walk through how the mechanics actually work, because "get funding to exercise your options" and "fund someone else's stock options for a cut of the upside" are two very different pitches, and this article is written for the second audience, the funder side, not the employee side.

What the platform actually does

EquityBee runs a two-sided marketplace. On one side are startup employees (current or departed) sitting on vested stock options they can't or don't want to pay cash to exercise. On the other side are accredited investors and funds looking for exposure to private, high-growth companies without writing a venture-fund-sized check. The employee applies, and EquityBee evaluates eligibility, verifies the stock option grant and documentation, and runs a background and credit check. If the employee qualifies, EquityBee packages the opportunity and presents it to its investor network as a funding request tied to a specific company, a specific number of vested options, and a specific strike price.

Investors browse these deals, described on EquityBee's investor-facing page, like listings on any marketplace: company name, sector, capital needed, and terms. If an investor decides to fund a deal, they cover the employee's exercise cost (and often the associated tax bill). The employee uses that money to exercise the options and becomes a shareholder of record, sometimes years before the company's growth story is done playing out. The employee keeps legal ownership of the shares throughout. EquityBee does not put the investor on the company's cap table, and the company itself is not a party to the deal and doesn't need to approve it, since the employee is simply exercising options they already earned.

How the deal is actually structured

This is the part accredited investors need to understand before they wire a dollar. EquityBee's funding is not a loan against the shares in the ordinary sense. It's typically structured as what the company calls a non-recourse arrangement, executed through a contract that gives the investor a percentage claim on the eventual proceeds if and only if the company has a successful liquidity event: an acquisition, an IPO, or another event that lets shareholders actually convert their paper stock into cash or freely tradable shares. If there's no liquidity event, the employee owes nothing back and the investor has no recourse to the employee's other assets. That "non-recourse" framing matters. It's the mechanism that makes this look and feel like an equity-style bet rather than a personal loan, even though functionally the investor is fronting capital against a specific, contingent payoff. At settlement, if there is a successful exit, the employee typically repays the original funding amount, plus any agreed interest, plus a pre-negotiated share of the proceeds, sometimes settled in cash, sometimes in shares once any lockup period ends.

Why does the 90-day window matter so much to this whole business existing in the first place? It's not a company-by-company quirk. It's largely an IRS artifact. Employees are usually granted incentive stock options (ISOs), which, as detailed guidance on option exercise rules explains, get favorable tax treatment (no ordinary income tax at exercise, and capital-gains treatment on eventual sale) only if exercised within about three calendar months of leaving the company. Wait past that window and, per the mechanics most equity-management platforms describe, the options convert to non-qualified stock options (NSOs), which trigger ordinary income tax at exercise on top of whatever the exercise cost already was. The default 90-day post-termination exercise window isn't arbitrary cruelty. It's the path of least tax complexity for the company. A minority of employers, including some well-known tech names, now extend that window to years rather than months, but the 90-day standard is still what most departing employees are working against, and it's the single biggest reason this funding niche exists at all: employees need capital fast, and that urgency produces deal flow for a funding marketplace.

The investor side: what you're actually buying

When you fund an EquityBee deal, you are not buying stock. You don't appear on the company's capitalization table, you get no voting rights, no board observer seat, and no information rights beyond what the employee is contractually obligated to pass along. What you're buying is a contractual claim, sometimes described as a variable forward contract, against a specific pool of already-vested common stock options at a company you had no hand in vetting beyond what EquityBee and the employee disclose. There's a real argument for why this can be attractive relative to buying secondary shares directly from an existing shareholder, or writing a check into a venture fund. Employee options are usually priced off older 409A valuations, typically well below the preferred stock that venture investors buy in a live financing round. Common stock carries none of the liquidation preferences, anti-dilution protection, or other downside cushioning that preferred shareholders negotiate for themselves. If the company exits well, common stock funded at an old, low strike price can produce outsized returns relative to what a late-stage secondary buyer paid for preferred shares in the same company. That's the pitch. It's also exactly why the downside is uglier than it looks on the surface.

How the three paths compare

Approach	What you actually own	Liquidity	Typical minimum	Primary risk
EquityBee-style option funding	Contractual claim on proceeds from a specific employee's vested options	None until a liquidity event, which could be years away or may never happen	Deal-dependent, individual deals can run from the low thousands to well into six figures	Binary outcome: total loss of funded capital if no exit, plus employee counterparty risk
Secondary share purchase	Direct equity ownership, on the cap table	None until a liquidity event, but you can sometimes resell your position again on a secondary market	Often higher, secondary deals frequently require larger checks and broker involvement	Buying in at a later-stage, higher valuation, still illiquid, and deal access is uneven
Venture fund investment	Limited partnership interest across a portfolio of companies	Locked up for the life of the fund, typically 10+ years	Often $25,000 to $250,000+ depending on the fund	Fund-level fees (management fee plus carry) eat into returns, plus manager selection risk

The venture fund path diversifies you across a portfolio and hands the diligence work to a manager, for a price: a management fee every year regardless of performance, plus a carried-interest cut of any gains. The secondary route gets you actual equity ownership with real cap-table rights, but usually at a valuation set in a much later, much pricier round, and secondary deal flow for individual accredited investors (rather than institutions) can be hard to source. EquityBee-style option funding sits in between: no fund fee drag, an entry price anchored to an older and often cheaper valuation, but zero diversification unless you deliberately spread capital across many deals yourself, and a payoff structure that depends on an individual employee honoring their contract as much as it depends on the company succeeding.

The risk section AIN readers actually need

I'm not going to soften this. If you're an accredited investor as defined by the SEC's accredited investor rules (generally $1 million in net worth excluding your primary residence, or income over $200,000 individually, $300,000 with a spouse, for the last two years) and you're considering funding option exercises through a platform like this, walk in with your eyes open on five points. First, this is a binary, all-or-nothing bet on liquidity. If the company never gets acquired and never IPOs, the employee owes you nothing under the non-recourse structure, and your funded capital is gone. There's no dividend stream, no interest payment along the way, no partial recovery mechanism. Second, time horizon is genuinely unpredictable. Venture-backed companies routinely take the better part of a decade or longer to reach an exit, if they reach one at all, and you have no say over that timeline. Third, you have zero control over the underlying business. You can't vote, you can't influence a down round, a pivot, or a sale price, and you're relying entirely on people you've never met to run the company well and eventually sell it or go public.

Fourth, and this is the one investors underestimate: the strike price you're funding was set by a 409A valuation, and 409A valuations are deliberately conservative. Appraisers price common stock below what preferred investors just paid, partly because common stock lacks the liquidation preferences and protections built into preferred shares, as standard guidance on 409A mechanics explains. That gap between the 409A strike price and a future exit valuation is exactly what creates the upside case. It's also exactly the kind of gap that can compress or vanish if the company's later rounds come with heavy liquidation preferences stacked ahead of common stockholders, meaning employees (and by extension, you) get paid only after preferred holders take their cut first. A big headline exit number does not always mean common shareholders see proportional upside. Fifth, and I'll say this plainly: EquityBee does not publish audited, third-party-verified return data on its funded deals. The company's own marketing pages reference aggregate transaction volume and cite realized gains, and I have no reason to doubt those figures reflect real deals, but they are self-reported by the platform that benefits from investor participation, not independently audited performance statistics you can diligence the way you'd diligence a fund's SEC-filed track record. Treat any return figure you see in a pitch deck or landing page as a marketing input, not underwriting data.

Who this is actually good for

Strip away the framing and this platform serves two audiences well, and a third poorly. It's genuinely useful for startup employees staring down a 90-day window with no cash for the exercise price and no appetite to walk away from years of equity. For them, non-recourse funding that costs nothing if the company never exits is a rational trade, especially against the alternative of just forfeiting the options. For accredited investors who already have venture or startup-adjacent exposure and want a satellite position, without fund fees, at a strike price often set well below the most recent preferred round, individual deals can make sense as a small, deliberately diversified sleeve of a broader portfolio. It's a poor fit for anyone who needs the money back on a defined schedule, can't model a total loss of the funded amount, or can't independently evaluate a private company's prospects, because the platform's vetting verifies that the option grant is real and the employee is who they say they are, not whether the underlying startup will succeed.

A due-diligence checklist before you fund a deal

• What is the company's stage, most recent funding round, and lead investors — and can you verify any of that independently, rather than taking the deal summary at face value?
• How old is the 409A valuation underlying the strike price, and has the company raised a materially higher round since then?
• What preference stack sits ahead of the common stock you'd effectively be funding, and how many dollars of liquidation preference need to be paid out before common shareholders see a dollar?
• What percentage of proceeds and what fees does the deal structure actually assign to you as the funder, and under what definition of a "successful" exit?
• How many other investors, if any, are participating in the same funding round for this employee, and does that change your effective allocation?
• Can you tolerate a multi-year (or indefinite) hold with zero interim liquidity and zero information rights along the way?
• Have you sized the position so a total loss doesn't meaningfully damage your broader portfolio?

If you can answer all seven honestly and the deal still looks attractive, this can be a reasonable way to add venture-style exposure without fund fees or a ten-year lockup on all your capital. Just don't let the "get in at an old, cheap valuation" pitch make you forget that cheap valuations exist because the company was smaller, riskier, and further from an exit when that price was set. The risk didn't disappear; it's just priced differently than in a Series C.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.